Efficacy of FOLFOX4 as adjuvant therapy in stage II colon cancer (CC): A new analysis of the MOSAIC trial according to risk factors

被引：0
|
作者：
Teixeira, L.
Hickish, T.
Tournigand, C.
Bachet, J.
Bonetti, A.
Rivera, F.
Boni, C.
Tabernero, J.
Andre, T.
De Gramont, A.
机构：
[1] Hop St Antoine, F-75571 Paris, France
[2] Dorset Canc Network, Bournemouth, Dorset, England
[3] Bournemouth Univ, Bournemouth, Dorset, England
[4] Grp Hosp Pitie Salpetriere, F-75634 Paris, France
[5] Dept Med Oncol, Legnago, Italy
[6] Hosp Univ Marques de Valdecilla, Santander, Spain
[7] Arcispedale S Maria Nuova, Reggio Emilia, Italy
[8] Vall dHebron Univ Hosp, Barcelona, Spain
[9] Hop La Pitie Salpetriere, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3524
引用
收藏
页数：2
相关论文
共 50 条
  • [1] FOLFOX4 as adjuvant treatment for stage II colon cancer (CC): Subpopulation data from the MOSAIC trial.
    Hickish, T
    Boni, C
    Navarro, M
    Tabernero, J
    Topham, C
    Bonetti, A
    Clingan, P
    Figer, A
    Andre, T
    De Gramont, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 274S - 274S
  • [2] FOLFOX4 as adjuvant therapy in elderly patients (pts) with colon cancer (CC): Subgroup analysis of the MOSAIC trial
    Toumigand, C.
    Andre, T.
    Bachet, J.
    Teixeira, L.
    Boni, C.
    Clingan, P. R.
    Hickish, T.
    Tabernero, J.
    De Gramont, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] FOLFOX4 in adjuvant treatment of colon cancer: Survival results from the mosaic trial
    de Gramont, A.
    Boni, C.
    Navarro, M.
    Tabernero, J.
    Hickish, T.
    Topham, C.
    Bonetti, A.
    Clingan, P.
    Lorenzato, C.
    Andre, T.
    ANNALS OF ONCOLOGY, 2007, 18 : VII23 - VII23
  • [4] Cost analysis of adjuvant therapy with XELOX or FOLFOX4 for colon cancer
    Xie, Q.
    Wen, F.
    Wei, Y. Q.
    Deng, H. X.
    Li, Q.
    COLORECTAL DISEASE, 2013, 15 (08) : 958 - 962
  • [5] FOLFOX4/XELOX in stage II-III colon cancer: Efficacy results of the Italian three or six colon adjuvant (TOSCA) trial.
    Sobrero, Alberto F.
    Lonardi, Sara
    Rosati, Gerardo
    Di Bartolomeo, Maria
    Ronzoni, Monica
    Pella, Nicoletta
    Scartozzi, Mario
    Banzi, Maria
    Zampino, M. Giulia
    Pasini, Felice
    Marchetti, Paolo
    Cantore, Maurizio
    Zaniboni, Alberto
    Rimassa, Lorenza
    Ciuffreda, Libero
    Ferrari, Daris
    Zagonel, Vittorina
    Maiello, Evaristo
    Rulli, Eliana
    Labianca, Roberto
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] FOLFOX4/XELOX in stage II-III colon cancer: Efficacy and safety results of the Italian Three Or Six Colon Adjuvant (TOSCA) trial
    Labianca, R.
    Lonardi, S.
    Rosati, G.
    Di Bartolomeo, M.
    Ronzoni, M.
    Pella, N.
    Scartozzi, M.
    Banzi, M.
    Zampino, M. G.
    Pasini, F.
    Marchetti, P.
    Cantore, M.
    Zaniboni, A.
    Rimassa, L.
    Ciuffreda, L.
    Barni, S.
    Zagonel, V.
    Maiello, E.
    Rulli, E.
    Sobrero, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] No advantage with FOLFOX4 for elderly and stage II colon cancer patients
    Kubicka, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (02) : 159 - 160
  • [8] FOLFOX4/XELOX in stage II-III colon cancer: early survival data of the Italian Three Or Six Colon Adjuvant (TOSCA) trial
    Zaniboni, A.
    Lonardi, S.
    Labianca, R.
    Di Bartolomeo, M.
    Rosati, G.
    Ronzoni, M.
    Pella, N.
    Banzi, M.
    Zampino, M. G.
    Pasini, F.
    Marchetti, P.
    Rimassa, L.
    Maiello, E.
    Bidoli, P.
    Cinieri, S.
    Barni, S.
    Ciuffreda, L.
    Beretta, G.
    Frontini, L.
    Rulli, E.
    Sobrero, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [9] FOLFOX4/XELOX in stage II-III colon cancer: Early survival data of the Italian three or six colon adjuvant (TOSCA) trial
    Roberto, Labianca
    Claudia, Mucciarini
    Paolo, Bidoli
    Domenico, Corsi
    Vincenzo, Montesarchio
    Maria, Bochicchio Anna
    Vincenzo, Iaffaioli
    Andrea, Ciarlo
    Sabino, De Placido
    Domenico, Amoroso
    Enrico, Cortesi
    Bruno, Daniele
    Dino, Amadori
    Daniele, Turci
    Silvia, Pelliccioni
    Saverio, Cinieri
    Alberto, Ravaioli
    Elena, Piazza
    Eliana, Rulli
    Alberto, Sobrero
    ANNALS OF ONCOLOGY, 2017, 28
  • [10] Cost-Effectiveness of Adjuvant FOLFOX Therapy for Stage III Colon Cancer in Japan Based on the MOSAIC Trial
    Shiroiwa, Takeru
    Takeuchi, Toshihiro
    Fukuda, Takashi
    Shimozuma, Kojiro
    Ohashi, Yasuo
    VALUE IN HEALTH, 2012, 15 (02) : 255 - 260
12345